Back to top
more

IQVIA (IQV)

(Delayed Data from NYSE)

$219.23 USD

219.23
1,418,430

+1.55 (0.71%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $219.01 -0.22 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Insperity Stock Appreciates 5% After Reporting Q3 Earnings Beat

by Zacks Equity Research

NSP witnesses a rise in WSEE in the third quarter of 2024.

Interpreting IQVIA (IQV) International Revenue Trends

by Zacks Equity Research

Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y

by Zacks Equity Research

Strength in the Research and Development, and Technology and Analytics segments drives IQV's top line in the third quarter of 2024.

Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes

by Zacks Equity Research

VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.

IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

IQVIA (IQV) delivered earnings and revenue surprises of 1.07% and 1.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Top Research Reports for Apple, Novo Nordisk & RTX

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Novo Nordisk A/S (NVO) and RTX Corporation (RTX), as well as a micro-cap stock FONAR Corporation (FONR).

IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know

by Zacks Equity Research

IQV's TAS and RD&S revenues are anticipated to have increased, while CSMS revenues are likely to have dipped in the third quarter of 2024.

Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EPAM Expands With First Derivative Buyout: What Should Investors Do?

by Zacks Equity Research

Epam Systems expands its AI capabilities in the financial space with the acquisition of First Derivative.

Here's Why You Should Retain IQVIA Holdings Shares Now

by Zacks Equity Research

While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure.

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

IQV Gains From Clinical Development Capabilities Amid Low Liquidity

by Zacks Equity Research

IQVIA's vast database, health-care-specific IT infrastructure and analytics-driven developments enable it to grow in the $300-billion market.

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sheraz Mian headshot

Top Analyst Reports for Amazon.com, Roche & GE Aerospace

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Roche Holding AG (RHHBY) and GE Aerospace (GE), as well as two micro-cap stocks Canterbury Park Holding Corporation (CPHC) and NVE Corporation (NVEC).

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Is Thermo Fisher (TMO) Up 1.6% Since Last Earnings Report?

by Zacks Equity Research

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IQVIA (IQV) Up 3.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain IQVIA (IQV) Stock for Now

by Zacks Equity Research

IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Waste Connections (WCN) Marginally Dips Despite Q2 Earnings Beat

by Zacks Equity Research

Waste Connections (WCN) records improved segmental performances in the second quarter of 2024.